GLOW Peptide Blend: Composition, Research Background and Specifications
GLOW is a 70mg lyophilised research blend that combines three peptides studied in tissue-remodelling research: GHK-Cu, BPC-157 and thymosin beta-4 (TB-4). This page explains what each component is, why they are often studied together, and the specifications of the material we supply.
For in vitro research use only. Not for human or animal use. Nothing on this page is medical advice.
What is the GLOW blend?
GLOW is a pre-mixed research blend: instead of three separate vials, the three peptides are combined and freeze-dried together in a single 70mg vial. GHK-Cu makes up the largest share of the blend, which gives the powder its characteristic blue colour from the copper complex.
Blends like GLOW are used in laboratory work where researchers want to study several compounds from the same research area together, with a consistent ratio between them from vial to vial.
The three components
Each component has its own detailed research guide covering chemistry, mechanism and published studies.
Specifications
| Product | GLOW peptide blend |
|---|---|
| Components | GHK-Cu, BPC-157, thymosin beta-4 (TB-4) |
| Total per vial | 70 mg (see product page for the batch composition) |
| Largest component | GHK-Cu |
| Appearance | Blue lyophilised powder (from the copper complex) |
| Form supplied | Lyophilised (freeze-dried) powder in a sealed vial |
Why these peptides are studied together
- Shared research areaAll three peptides are studied in models of tissue repair, remodelling and skin biology.
- Different mechanismsGHK-Cu is linked to collagen and gene expression, BPC-157 to growth-factor and angiogenesis pathways, and TB-4 to actin and cell migration.
- Complementary questionsCombining them allows researchers to explore whether different pathways interact in the same experimental model.
- Consistent ratioA pre-mixed blend keeps the proportion between the three compounds the same across experiments.
Limitations of the evidence
- Published research mostly studies each peptide on its own; there is very little published research on this specific combination.
- Findings for individual peptides cannot be assumed to apply to the blend.
- Much of the evidence for each component comes from cell and animal models.
- Interactions between the components in a single solution are not well characterised.
How blends are tested
Separating and measuring several peptides in one sample is more complex than testing a single compound. Our blends are independently tested by Janoshik, and purity figures for blends may also reflect the manufacturer’s data on the individual raw materials. Read more on our Quality & Testing page.
Regulatory status
None of the components of GLOW is approved as a medicine in the UK, and the blend is not a licensed medicinal or cosmetic product. It is sold strictly for in vitro laboratory research and is not intended for human or animal use.
Storage and handling in the lab
- Store lyophilised powder at −20 °C, protected from light and moisture, for long-term stability.
- Allow the vial to reach room temperature before opening to reduce condensation.
- Once reconstituted for experiments, keep refrigerated (2–8 °C) and avoid repeated freeze–thaw cycles.
- Avoid vigorous shaking, which can damage the longer peptides in the blend.
Order GLOW
GLOW is available through our official store, sterling-research.com.
Related research compounds
Frequently asked questions
What is in the GLOW peptide blend?
GLOW combines three research peptides in one 70mg vial: GHK-Cu, BPC-157 and thymosin beta-4 (TB-4). GHK-Cu is the largest component.
Why is the GLOW powder blue?
The blue colour comes from GHK-Cu, a peptide bound to copper. Copper complexes of this kind are naturally blue.
What is the difference between GLOW and KLOW?
KLOW contains the same three peptides as GLOW plus a fourth, KPV, a tripeptide studied in inflammation research. KLOW is supplied as an 80mg vial.
Has the GLOW blend been studied as a combination?
Very little published research exists on this specific combination. Most studies examine GHK-Cu, BPC-157 and thymosin beta-4 individually.
How should GLOW be stored?
Lyophilised GLOW should be stored at −20 °C, protected from light and moisture. Reconstituted solutions should be kept refrigerated and not repeatedly frozen and thawed.
This page is for scientific information only. Sterling Peptides Ltd supplies the GLOW blend strictly for in vitro laboratory research. Not for human or animal use, and not for diagnostic, therapeutic or cosmetic purposes. Questions: [email protected]